The United States represents a leading market for intensity modulated radiotherapy, driven by a high cancer burden, advanced oncology infrastructure, and strong adoption of cutting-edge radiation therapy technologies. Increasing investments in precision cancer treatment, growing availability of specialized cancer centers, and continuous technological innovation are supporting the widespread use...